journal article·2016-08-03

A Donor–Acceptor Conjugated Polymer with Alternating Isoindigo Derivative and Bithiophene Units for Near-Infrared Modulated Cancer Thermo-Chemotherapy

Dong-Dong Li, Jun-Xia Wang, Yan Ma, Hai-Sheng Qian, Dong Wang, Li Wang, Guobing Zhang, Longzhen Qiu, Yu-Cai Wang, Xian-Zhu Yang

Publisher page

Abstract

Conjugated polymers containing alternating donor/acceptor units have strong and sharp absorbance peaks in near-infrared (NIR) region, which could be suitable for photothermal therapy. However, these polymers as photothermal transducers are rarely reported because of their water insolubility, which limits their applications for cancer therapy. Herein, we report the donor-acceptor conjugated polymer PBIBDF-BT with alternating isoindigo derivative (BIBDF) and bithiophene (BT) units as a novel photothermal transducer, which exhibited strong near-infrared (NIR) absorbance due to its low band gap (1.52 eV). To stabilize the conjugated polymer physiological environments, we utilized an amphiphilic copolymer, poly(ethylene glycol)-block-poly(hexyl ethylene phosphate) (mPEG-b-PHEP), to stabilize PBIBDF-BT-based nanoparticles (PBIBDF-BT@NPPPE) through a single emulsion method. The obtained nanoparticles PBIBDF-BT@NPPPE showed great stability in physiological environments and excellent photostability. Moreover, the PBIBDF-BT@NPPPE exhibited high photothermal conversion efficiency, reaching 46.7%, which is relatively high compared with those of commonly used materials for photothermal therapy. Accordingly, in vivo and in vitro experiments demonstrated that PBIBDF-BT@NPPPE exhibits efficient photothermal anticancer efficacy. More importantly, PBIBDF-BT@NPPPE could simultaneously encapsulate other types of therapeutic agents though hydrophobic interactions with the PHEP core and achieve NIR-triggered intracellular drug release and a synergistic combination therapy of thermo-chemotherapy for the treatment of cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer therapeutics and mechanisms · Covalent Organic Framework Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biological and Medical Engineering, Hefei University of Technology, Hefei, Anhui 230009, China

Academy of Opto-Electronic Technology, Hefei University of Technology, Hefei, Anhui 230009, China

School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China

Funding

Ministry of Education of the People's Republic of China · Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (43)

Show source-provided references
1. 10.1002/adfm.20150143410.1002/adfm.201501434 ↗
2. 10.1002/smll.20140324910.1002/smll.201403249 ↗
3. 10.1021/nn500722y10.1021/nn500722y ↗
4. 10.1002/adhm.20150045310.1002/adhm.201500453 ↗
5. 10.1002/adfm.20150414210.1002/adfm.201504142 ↗
6. 10.1038/8668410.1038/86684 ↗
7. 10.1016/j.nantod.2015.06.00410.1016/j.nantod.2015.06.004 ↗
8. 10.1002/adfm.20150301510.1002/adfm.201503015 ↗
9. 10.1021/nn401187c10.1021/nn401187c ↗
10. 10.1002/adma.20150194210.1002/adma.201501942 ↗
11. 10.1002/smll.20140226910.1002/smll.201402269 ↗
12. 10.1021/nn505468v10.1021/nn505468v ↗
13. 10.1016/j.biomaterials.2014.03.04210.1016/j.biomaterials.2014.03.042 ↗
14. 10.1038/nnano.2009.23110.1038/nnano.2009.231 ↗
15. 10.1002/adfm.20150517510.1002/adfm.201505175 ↗
16. 10.1002/adfm.20140276210.1002/adfm.201402762 ↗
17. 10.1016/j.biomaterials.2015.06.04310.1016/j.biomaterials.2015.06.043 ↗
18. 10.1021/nl100996u10.1021/nl100996u ↗
19. 10.1002/adma.20140182510.1002/adma.201401825 ↗
20. 10.1039/c3nr06242b10.1039/c3nr06242b ↗
21. 10.1021/ja401349710.1021/ja4013497 ↗
22. 10.1039/C5NR02269J10.1039/C5NR02269J ↗
23. 10.1021/nn400334y10.1021/nn400334y ↗
24. 10.1016/j.biomaterials.2013.07.03410.1016/j.biomaterials.2013.07.034 ↗
25. 10.1016/j.biomaterials.2013.08.07510.1016/j.biomaterials.2013.08.075 ↗
26. 10.1002/adhm.20130063610.1002/adhm.201300636 ↗
27. 10.1002/adfm.20130155510.1002/adfm.201301555 ↗
28. 10.1021/nn301539m10.1021/nn301539m ↗
29. 10.1002/adfm.20130246310.1002/adfm.201302463 ↗
30. 10.1002/adfm.20140233810.1002/adfm.201402338 ↗
31. 10.1002/adma.20120221110.1002/adma.201202211 ↗
32. 10.1021/nn401717910.1021/nn4017179 ↗
33. 10.1002/mabi.20120024110.1002/mabi.201200241 ↗
34. 10.1002/smll.20140209210.1002/smll.201402092 ↗
35. 10.1039/c3cc48695h10.1039/c3cc48695h ↗
36. 10.1021/am506872310.1021/am5068723 ↗
37. 10.1002/smll.20150055010.1002/smll.201500550 ↗
38. 10.1002/adma.20130590510.1002/adma.201305905 ↗
39. 10.1021/jp064341w10.1021/jp064341w ↗
40. 10.1021/nl201400z10.1021/nl201400z ↗
41. 10.1039/c2cc34463g10.1039/c2cc34463g ↗
42. 10.1021/acsnano.5b0582510.1021/acsnano.5b05825 ↗
43. 10.1021/nn203293t10.1021/nn203293t ↗